Board of Gufic Biosciences approves Scheme of Amalgamation

Capital Market

Last Updated : Nov 26 2016 | 12:01 AM IST

Of Gufic Stridden Bio-Pharma Private Limited with the Company

The Board of Gufic Biosciences at the meeting held on 24th November 2016 has approved the Scheme of Amalgamation of M/s. Gufic Stridden Bio-Pharma Private Limited with the Company, subject to the necessary approvals.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

Tata Steel to hold EGM

GMR Infrastructure to announce Q2 results

Tata Steel announces change in directorate

Board of La Tim Metal & Industries approves preferential issue of shares

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 25 2016 | 9:41 AM IST

Explore News

Stock Market LIVE Updates Stocks to Watch Today Trump International Organisation Withdrawal Order IMD Weather Forecast Today Stocks to Buy Today US Denmark Greenland Talks Gold and Silver Price Today UK Dev's Law Stock Market Before Budget 2026 Seeds Bill